Medical Technology and Life Expectancy: Evidence from the Antitoxin Treatment of Diphtheria
American Economic Journal: Economic Policy · 01.05.2026 · 18 (2) · 441-476
DOI: 10.1257/pol.20240087 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Economic Journal: Economic Policy, erschienen am 01.05.2026. Verfasst von Philipp Ager und 2 weiteren Autor:innen. Die Arbeit nennt 70 Literaturangaben.
Abstract (Originalsprache)
We examine the impact of the free supply of diphtheria antitoxin, the first effective medical treatment for an infectious disease, on the historical health transition in Massachusetts. Using newly collected municipality-level data on the distribution of antitoxin and information from over 1.5 million death certificates from 1880 to 1914, we find that the rapid availability of antitoxin treatment significantly increased life expectancy at young ages. Our findings suggest that medicine, combined with an effective public health policy, played a more important role in improving life expectancy in the early twentieth century than previously thought. (JEL H75, I12, I18, J13, N31)
Zitieren
APA
Ager, P., Hansen, C. W., & Lin, P. Z. (2026). Medical Technology and Life Expectancy: Evidence from the Antitoxin Treatment of Diphtheria. American Economic Journal: Economic Policy, 18(2), 441-476. https://doi.org/10.1257/pol.20240087
Vancouver
Ager P, Hansen CW, Lin PZ. Medical Technology and Life Expectancy: Evidence from the Antitoxin Treatment of Diphtheria. American Economic Journal: Economic Policy. 2026;18(2):441-476. doi:10.1257/pol.20240087
BibTeX
@article{Ager2026,
author = {Ager, Philipp and Hansen, Casper W. and Lin, Peter Z.},
title = {Medical Technology and Life Expectancy: Evidence from the Antitoxin Treatment of Diphtheria},
journal = {American Economic Journal: Economic Policy},
year = {2026},
volume = {18},
number = {2},
pages = {441--476},
doi = {10.1257/pol.20240087}
}
EUVIMED